Adicet Bio Newsroom

Adicet Bio Highlights Key 2025 Milestones Following 2024 Progress

BenzingaJan 9 05:13

Express News | Adicet Bio Inc - Preliminary Data for Adi-001 in Ln Expected in 1H25

BreakingsJan 9 05:11

Express News | Adicet Bio Provides Corporate Update and Highlights Expected 2025 Milestones

BreakingsJan 9 05:10

H.C. Wainwright Remains a Hold on Adicet Bio (ACET)

TipRanksDec 21, 2024 01:50 · Ratings

Adicet Bio Advances With Phase 1 Trial of ADI-270

TipRanksDec 20, 2024 05:31

HC Wainwright & Co. Reiterates Neutral on Adicet Bioto Neutral

BenzingaDec 20, 2024 00:39

Express News | Adicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of Adi-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma

BreakingsDec 19, 2024 20:00

Adicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma

BusinesswireDec 19, 2024 20:00

Express News | Adicet Bio Appoints Julie Maltzman, M.d. as Chief Medical Officer

BreakingsDec 18, 2024 20:00

Adicet Bio Appoints Julie Maltzman, M.D. as Chief Medical Officer

BusinesswireDec 18, 2024 20:00

Adicet Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BusinesswireNov 30, 2024 05:44

Express News | Adicet Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

BreakingsNov 30, 2024 05:44

Adicet Bio Clears Debts With Banc of California

TipRanksNov 28, 2024 06:30

Adicet Bio Reports Q3 2024 Results and Clinical Progress

TipRanksNov 21, 2024 11:57

Adicet Bio To Present At Jefferies London Healthcare Conference; Webcast At 7:30 AM ET

RTTNewsNov 19, 2024 19:34

Adicet Bio Advances Cancer and Autoimmune Trials

TipRanksNov 19, 2024 05:34

Adicet Opens Enrollment For ADI-270 Phase 1 Clinical Trial In Metastatic/Advanced Clear Cell Renal Cell Carcinoma; First Gamma Delta CAR T Cell Therapy With The Potential To Address Solid Tumors Entering Clinical Trials; Preliminary Phase 1 Clinical...

BenzingaNov 19, 2024 05:01

Express News | Adicet Opens Enrollment for Adi-270 Phase 1 Clinical Trial in Metastatic/Advanced Clear Cell Renal Cell Carcinoma

BreakingsNov 19, 2024 05:00

Adicet Opens Enrollment for ADI-270 Phase 1 Clinical Trial in Metastatic/Advanced Clear Cell Renal Cell Carcinoma

BusinesswireNov 19, 2024 05:00

HC Wainwright & Co. Reiterates Neutral on Adicet Bio

BenzingaNov 19, 2024 00:55